Literature DB >> 28364981

Heightened Pelvic Floor Muscle Tone and Altered Contractility in Women With Provoked Vestibulodynia.

Mélanie Morin1, Yitzchak M Binik2, Daniel Bourbonnais3, Samir Khalifé4, Stéphane Ouellet5, Sophie Bergeron6.   

Abstract

BACKGROUND: Pelvic floor muscle (PFM) dysfunctions are reported to be involved in provoked vestibulodynia (PVD). Although heightened PFM tone has been suggested, the relative contribution of active and passive components of tone remains misunderstood. Likewise, alterations in PFM contractility have been scarcely studied. AIMS: To compare PFM tone, including the relative contribution of its active and passive components, and muscular contractility in women with PVD and asymptomatic controls.
METHODS: Fifty-six asymptomatic women and 56 women with PVD participated in the study. The PVD diagnosis was confirmed by a gynecologist based on a standardized examination. OUTCOMES: PFM function was evaluated using a dynamometric speculum combined with surface electromyography (EMG). PFM general tone was evaluated in static conditions at different vaginal apertures and during repeated dynamic cyclic stretching. The active contribution of tone was characterized using the ratio between EMG in a static position and during stretching and the proportion of women presenting PFM activation during stretching. Contribution of the passive component was evaluated using resting forces, stiffness, and hysteresis in women sustaining a negligible EMG signal during stretching. PFM contractility, such as strength, speed of contraction, coordination, and endurance, also was assessed during voluntary isometric efforts.
RESULTS: Greater PFM resting forces and stiffness were found in women with PVD compared with controls, indicating an increased general tone. An increased active component also was found in women with PVD because they presented a superior EMG ratio, and a larger proportion of them presented PFM activation during stretching. Higher passive properties also were found in women with PVD. Women with PVD also showed decreased strength, speed of contraction, coordination, and endurance compared with controls. CLINICAL IMPLICATIONS: Findings provide further evidence of the contribution of PFM alterations in the etiology of PVD. These alterations should be assessed to provide patient-centered targeted treatment options. STRENGTHS AND LIMITATIONS: The use of a validated tool investigating PFM alterations constitutes a strength of this study. However, the study design does not allow the determination of the sequence of events in which these muscle alterations occurred-before or after the onset of PVD.
CONCLUSION: Findings support the involvement of active and passive components of PFM tone and an altered PFM contractility in women with PVD. Morin M, Binik YM, Bourbonnais D, et al. Heightened Pelvic Floor Muscle Tone and Altered Contractility in Women With Provoked Vestibulodynia. J Sex Med 2017;14:592-600.
Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dynamometer; Dyspareunia; Electromyography; Muscle Strength; Muscle Tensions; Muscle Tone; Pelvic Floor; Provoked Vestibulodynia; Vulvodynia

Mesh:

Year:  2017        PMID: 28364981     DOI: 10.1016/j.jsxm.2017.02.012

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  16 in total

1.  Can maximal voluntary pelvic floor muscle contraction reduce vaginal resting pressure and resting EMG activity?

Authors:  Ingrid Naess; Kari Bø
Journal:  Int Urogynecol J       Date:  2018-03-12       Impact factor: 2.894

Review 2.  High-Intensity Laser Therapy (HILT) as an Emerging Treatment for Vulvodynia and Chronic Musculoskeletal Pain Disorders: A Systematic Review of Treatment Efficacy.

Authors:  Małgorzata Starzec-Proserpio; Marcela Grigol Bardin; Julie Fradette; Le Mai Tu; Yves Bérubè-Lauzière; Josianne Paré; Marie-Soleil Carroll; Mélanie Morin
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

3.  Are clinically recommended pelvic floor muscle relaxation positions really efficient for muscle relaxation?

Authors:  Özge Çeliker Tosun; Damla Korkmaz Dayıcan; İrem Keser; Sefa Kurt; Meriç Yıldırım; Gökhan Tosun
Journal:  Int Urogynecol J       Date:  2022-02-24       Impact factor: 1.932

Review 4.  Vulvodynia.

Authors:  Sophie Bergeron; Barbara D Reed; Ursula Wesselmann; Nina Bohm-Starke
Journal:  Nat Rev Dis Primers       Date:  2020-04-30       Impact factor: 52.329

5.  Surface electromyography of the pelvic floor at 6-8 weeks following delivery: a comparison of different modes of delivery.

Authors:  Kai-Min Guo; Lang-Chi He; Yan Feng; Liu Huang; Abraham Nick Morse; Hui-Shu Liu
Journal:  Int Urogynecol J       Date:  2021-06-16       Impact factor: 1.932

Review 6.  Chronic Pelvic Pain: Assessment, Evaluation, and Objectivation.

Authors:  Maria Beatrice Passavanti; Vincenzo Pota; Pasquale Sansone; Caterina Aurilio; Lorenzo De Nardis; Maria Caterina Pace
Journal:  Pain Res Treat       Date:  2017-11-20

7.  Exploring Pain-Related Anxiety and Depression in Female Patients With Provoked Vulvodynia With Associated Overactive Pelvic Floor Muscle Dysfunction.

Authors:  Vaishnavi Govind; Jill M Krapf; Leia Mitchell; Karissa Barela; Hillary Tolson; Jaqueline Casey; Andrew T Goldstein
Journal:  Sex Med       Date:  2020-06-24       Impact factor: 2.491

8.  Reliability, validity and responsiveness of pelvic floor muscle surface electromyography and manometry.

Authors:  Ingeborg Hoff Brækken; Britt Stuge; Anne Therese Tveter; Kari Bø
Journal:  Int Urogynecol J       Date:  2021-06-17       Impact factor: 2.894

Review 9.  Vulvodynia-It Is Time to Accept a New Understanding from a Neurobiological Perspective.

Authors:  Rafael Torres-Cueco; Francisco Nohales-Alfonso
Journal:  Int J Environ Res Public Health       Date:  2021-06-21       Impact factor: 3.390

Review 10.  Vulvodynia: a consideration of clinical and methodological research challenges and recommended solutions.

Authors:  Serena Corsini-Munt; Kate M Rancourt; Justin P Dubé; Meghan A Rossi; Natalie O Rosen
Journal:  J Pain Res       Date:  2017-10-09       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.